Author Archives: Simon

MonTa Biosciences will be presenting very strong data on our immuno oncology technology at the annual meeting of AACR in Orlando

MonTa Biosciences will be presenting very strong data on our immuno oncology technology with our [...]

MonTa Biosciences open clinical sites in Madrid and Bruxelles

MonTa Bisciences have in January opened additionally 4 clinical sites in Madrid and Bruxelles. We [...]

MonTa Biosciences Announces Investment to Complete the Ongoing Phase I Monotherapy Trial on MBS8, and a Combination Phase IB/IIA Trial with MBS8 and a Currently Approved Oncology Drug.

COPENHAGEN, Denmark, October 20, 2022 — MonTa Biosciences, a clinical-stage biotechnology company focused on stimulating [...]

MonTa Biosciences featured in Nature pharmadealmakers magazine

MonTa Biosciences was featured as an upcoming biotech oncology company in Natures edition of pharmadealmakers. [...]

MonTa Biosciences successfully dose first patient in phase I clinical trial

MonTa Biosciences this week successfully enrolled and dosed the first cancer patient in our phase [...]

MonTa Biosciences awarded approval from regulatory agencies to start phase I study

MonTa Biosciences was awarded with positive feedback from the regulatory agency in Denmark to initiate [...]

MonTa Biosciences becomes a Clinical Stage Company

MonTa Biosciences today announced that the company has transitioned from a preclinical to a Clinical [...]

MonTa Biosciences initiates collaboration with NCI under the Nanotechnology Characterization Laboratory program

MonTa Biosciences has successfully gone through a tough selection process and been enrolled into the [...]

MonTa Biosciences successfully completed regulatory advice meeting with the Danish Medicines Agency

MonTa Biosciences have completed our regulatory meeting with the Danish Medicines Agency to align views [...]

MonTa Biosciences recruits Chief Medical Officer Steven Glazer to bring MonTas lead candidate MBS8 into clinical development

Steven Glazer is a well renowned clinical expert and biotech entrepreneur who has a strong [...]

MonTa Biosciences close a Series A investment from existing investors to complete phase I in cancer patients

MonTa Biosciences announced completion of a Series A investment from existing investor Consolidated Biosciences Aps [...]